Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

EMA's Guido Rasi

Rasi nominated to be EMA chief

June 10, 2011 Research and Development, Sales and Marketing EMA, Guido Rasi, Thomas Lönngren

The European Medicines Agency has nominated Italy’s Guido Rasi to be its next head, after a protracted and messy search. …
News
lilly_andrew_hotchkiss

Lilly promotes Andrew Hotchkiss

June 9, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Lilly has appointed Andrew Hotchkiss president of its operations in Australia, Canada and Europe. Andrew has been with the company …
Appointment

Daiichi Sankyo: Europe poses huge challenge for pharma

June 9, 2011 Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing

Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …
News

NICE thumbs up for Allergan’s Ozurdex

June 9, 2011 Sales and Marketing Allergan, BRVO, CVRO, NICE, Ozurdex

In draft guidance NICE has recommended the use of Allergan’s eye treatment Ozurdex.NICE’s final decision on Ozurdex (dexamethasone) is expected …
News

Price transparency and timing at risk, warns EFPIA

June 9, 2011 Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing

Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …
News
ABPI's Richard Barker

The Pharmafocus Interview: Richard Barker

June 9, 2011 Research and Development, Sales and Marketing ABPI, Dr Richard Barker, vita

Dr Richard Barker has been at the helm of the UK pharma industry for over six years, but is now …
Feature

Free webinar on An Introduction to Scientific Advice in the EU

June 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Following the success of the recent pharmacovigilance webinars delivered, Wainwright Associates are offering a webinar on An Introduction to Scientific …
News
Press release

Red Kite to merge with MSI

June 8, 2011 Sales and Marketing Cello, MSI, Red Kite, pharmaceutical marketing

Strategic marketing group Cello has expanded its healthcare portfolio with the acquisition of consultancy firm Red Kite. The move has …
News

UK suing Servier over alleged generic blocking

June 7, 2011 Sales and Marketing Peridopril, Servier, generics

The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …
News

Bayer submits Lucentis rival for European approval

June 7, 2011 Sales and Marketing Bayer, Lucentis, Regeneron, VEGF Trap-Eye

Bayer Healthcare has submitted its new eye drug to European regulators for approval to treat age-related macular degeneration (wet AMD). …
News

Merck plans cancer drug submissions later this year

June 7, 2011 Research and Development, Sales and Marketing Merck & Co, ridaforolimus

Merck & Co is to submit its oral investigational cancer drug ridaforolimus to European and US regulators later this year …
News
Merck Serono headquarters

Erbitux meets gold standard in rectal cancer

June 7, 2011 Research and Development, Sales and Marketing Erbitux, Merck Serono, rectal cancer

Studies of Merck Serono’s Erbitux in rectal cancer have shown improved overall survival, a gold standard measure in oncology trials. …
News

New head of finance at Bayer

June 7, 2011 Sales and Marketing appointment, sales and marketing

Bayer has appointed Peter Müller as its new head of finance. Currently head of the corporate finance unit within the …
Appointment
almirall_daniel_martinez_carretero

Almirall appoints Daniel Martínez Carretero as finance head

June 6, 2011 Sales and Marketing appointment, sales and marketing

Spanish pharma company Almirall has appointed Daniel Martínez Carretero as its chief financial officer. In addition to Finance, Daniel will …
Appointment
Roche

Roche impresses at ASCO with vemurafenib

June 6, 2011 Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026